Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
ClinicalTrials.gov study NCT04584710. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
ClinicalTrials.gov study NCT06971094. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
ClinicalTrials.gov study NCT05674045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)
ClinicalTrials.gov study NCT06193239. IPD Sharing: NO. Countries: 3. Publications: 0.
Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin
ClinicalTrials.gov study NCT02343926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
ClinicalTrials.gov study NCT00610103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT07168902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04711148. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT05996380. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
ClinicalTrials.gov study NCT00600054. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer
ClinicalTrials.gov study NCT00707889. IPD Sharing: Not stated. Countries: 14. Publications: 0.
HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial
ClinicalTrials.gov study NCT05886465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia
ClinicalTrials.gov study NCT03559387. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT06615700. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
ClinicalTrials.gov study NCT01990196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03392246. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
ClinicalTrials.gov study NCT04039477. IPD Sharing: NO. Countries: 5. Publications: 0.
Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy
ClinicalTrials.gov study NCT06100887. IPD Sharing: NO. Countries: 1. Publications: 0.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
ClinicalTrials.gov study NCT06798896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)
ClinicalTrials.gov study NCT06402630. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.